Leonardus H.t. van der Ploeg is CSO at RHYTHM PHARMACEUTICALS, INC. (RYTM). They have made 5 open-market trades across 1 company since 2018, most recently 2019-05-31.
CIK 0001615726
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RYTM | 47,339 | $5.0M |
Shares reported on the most recent Form 4, priced at the 2019-06-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RYTM | SELL | 2019-05-30 | 2019-06-03 | $25.21 | $252K | -8.0% | -17.5% | -12.8% |
| RYTM | SELL | 2019-05-29 | 2019-05-30 | $25.51 | $128K | -10.1% | -13.0% | -11.2% |
| RYTM | SELL | 2019-05-28 | 2019-05-30 | $25.42 | $381K | -10.1% | -13.0% | -11.2% |
| RYTM | SELL · 10b5-1 | 2019-01-16 | 2019-01-18 | $30.00 | $6K | -10.9% | -1.4% | -12.1% |
| RYTM | SELL | 2018-11-02 | 2018-11-06 | $30.09 | $1.1M | -3.7% | -6.5% | -6.6% |
| RYTM | SELL | 2018-09-25 | 2018-09-27 | $29.80 | $1.9M | -15.7% | -10.3% | -8.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.